glp 1 select trial GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction glp-1 receptor agonist kidney outcomes

January Product Spotlight: Oral Liposomal BPC-157 What is BPC-157

Comparative Analysis of EspF from Enteropathogenic and Enterohemorrhagic Escherichia coli in Alteration of Epithelial Barrier Function

Judicial Panel on Multidistrict Litigation (JPML) ruled that the cases should proceed as a separate multidistrict litigation (MDL) in federal court in Philadelphia, rather than being folded into an existing MDL involving gastrointestinal side effects linked to the same class of medications

Danyal, M., Shah, S.I.A., Hassan, M.S.U

Find movements you enjoy, like dancing, walking the dog, or yoga, and itll never feel like a chore